endosergЭндокринная хирургияEndocrine Surgery2306-35132310-3965Типография «Печатных дел Мастер»10.14341/2306-3513-2009-1-24-35endoserg-3990Research ArticleСтатьиArticlesПо материалам клинических рекомендаций по диагностике синдрома КушингаPo materialam klinicheskikh rekomendatsiy po diagnostike sindroma KushingaBel'tsevichD G-20091503200931№1 (2009)2435Copyright © Bel'tsevich D.G., 20092009Bel'tsevich D.G.Bel'tsevich D.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.surg-endojournals.ru/jour/article/view/3990

Полный текст: The diagnosis of Cushing’s syndrome:an endocrine society clinical practice guideline. Авторы: L.K. Nieman, B.M.K. Biller, J. W. Findling, J.Newell-Price, M.O. Savage, P.M. Stewart, and V.M. Montori Journal of Clinical Endocrinology & Metabolism, May 2008, 93(5): 1526-1540

ReferencesL.K. Nieman, B.M.K. Biller, J. W. Findling, J.Newell-Price, M.O. Savage, P.M. Stewart, and V.M. Montori. The diagnosis of Cushing’s syndrome:an endocrine society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, May 2008, 93(5): 1526-1540L.K. Nieman, B.M.K. Biller, J. W. Findling, J.Newell-Price, M.O. Savage, P.M. Stewart, and V.M. Montori. The diagnosis of Cushing’s syndrome:an endocrine society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, May 2008, 93(5): 1526-1540Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y,Flottorp S, Guyatt GH, Harbour RT, Haugh MC, HenryD, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O’Connell D,Oxman AD, Phillips B, Schunemann HJ, Edejer TT,Varonen H, Vist GE, Williams Jr JW, Zaza S 2004 Grading quality of evidence and strength ofrecommendations. BMJ 328:1490Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y,Flottorp S, Guyatt GH, Harbour RT, Haugh MC, HenryD, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O’Connell D,Oxman AD, Phillips B, Schunemann HJ, Edejer TT,Varonen H, Vist GE, Williams Jr JW, Zaza S 2004 Grading quality of evidence and strength ofrecommendations. BMJ 328:1490Elamin MB, Murad MH, Mullan R, Erickson D, HarrisK, Nadeem S, Ennis R, Erwin PJ, Montori VM 2008 Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses. J Clin Endocrinol Metab 93:1553-1562Elamin MB, Murad MH, Mullan R, Erickson D, HarrisK, Nadeem S, Ennis R, Erwin PJ, Montori VM 2008 Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses. J Clin Endocrinol Metab 93:1553-1562Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, GUyatt GH, Montori VM 2008 A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the GRADE system. J Clin Endocrinol Metab 93:666-673Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, GUyatt GH, Montori VM 2008 A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the GRADE system. J Clin Endocrinol Metab 93:666-673Etxabe J, Vazquez JA 1994 Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479-484Etxabe J, Vazquez JA 1994 Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479-484Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J 2001 Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 86:117-123Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J 2001 Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 86:117-123Nugent CA, Warner HR, Dunn JT, Tyler FH 1964 Probability theory in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 24:621-627Nugent CA, Warner HR, Dunn JT, Tyler FH 1964 Probability theory in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 24:621-627Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F 2007 The dexamethasonesup ressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf) 66:251-257Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F 2007 The dexamethasonesup ressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf) 66:251-257Ross EJ, Linch DC 1982 Cushing’s syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2:646-649Ross EJ, Linch DC 1982 Cushing’s syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2:646-649Yanovski JA, Cutler GB, Jr., Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudoCushing’s states. JAMA 269:2232-2238Yanovski JA, Cutler GB, Jr., Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudoCushing’s states. JAMA 269:2232-2238Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, et al. 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing’s disease. Pathophysiologic and diagnostic implications. N Engl J Med 314:1329-1335Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, et al. 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing’s disease. Pathophysiologic and diagnostic implications. N Engl J Med 314:1329-1335Cushing H 1932 The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 50:137-195Cushing H 1932 The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 50:137-195Plotz CM, Knowlton AI, Ragan C 1952 The natural history of Cushing’s syndrome. Am J Med 13:597-614Plotz CM, Knowlton AI, Ragan C 1952 The natural history of Cushing’s syndrome. Am J Med 13:597-614Swearingen B, Biller BM, Barker 2nd FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT 1999 Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 130:821-824Swearingen B, Biller BM, Barker 2nd FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT 1999 Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 130:821-824Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672Wei L, MacDonald TM, Walker BR 2004 Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764-770Wei L, MacDonald TM, Walker BR 2004 Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764-770Bourdeau I, Bard C, Noel B, Leclerc I, Cordeau MP, Belair M, Lesage J, Lafontaine L, Lacroix A 2002 Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87:1949-1954Bourdeau I, Bard C, Noel B, Leclerc I, Cordeau MP, Belair M, Lesage J, Lafontaine L, Lacroix A 2002 Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87:1949-1954Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW 1995 Bone mineral density and bone turnover before and after surgical cure of Cushing’s syndrome. J Clin Endocrinol Metab 80:2859-2865Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW 1995 Bone mineral density and bone turnover before and after surgical cure of Cushing’s syndrome. J Clin Endocrinol Metab 80:2859-2865Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK 2006 Long-term impaired quality of life in Cushing’s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447-453Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK 2006 Long-term impaired quality of life in Cushing’s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447-453Sarlis NJ, Chanock SJ, Nieman LK 2000 Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J Clin Endocrinol Metab 85:42-47Sarlis NJ, Chanock SJ, Nieman LK 2000 Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J Clin Endocrinol Metab 85:42-47Reincke M 2000 Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am 29:43-56Reincke M 2000 Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am 29:43-56Terzolo M, Reimondo G, Bovio S, Angeli A 2004 Subclinical Cushing’s syndrome. Pituitary 7:217-223Terzolo M, Reimondo G, Bovio S, Angeli A 2004 Subclinical Cushing’s syndrome. Pituitary 7:217-223Tsagarakis S, Vassiliadi D, Thalassinos N 2006 Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J Endocrinol Invest 29:471-482Tsagarakis S, Vassiliadi D, Thalassinos N 2006 Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J Endocrinol Invest 29:471-482Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH, 3rd, Nwariaku FE 2007 “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900-905Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH, 3rd, Nwariaku FE 2007 “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900-905Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB, Savage MO 2005 Final adult height and body mass index after cure of paediatric Cushing’s disease. Clin Endocrinol (Oxf) 62:466-472Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB, Savage MO 2005 Final adult height and body mass index after cure of paediatric Cushing’s disease. Clin Endocrinol (Oxf) 62:466-472Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI, Clark AJ, Reznek RH, Grossman AB, Savage MO 2004 Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing’s syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 61:553-559Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI, Clark AJ, Reznek RH, Grossman AB, Savage MO 2004 Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing’s syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 61:553-559Magiakou MA, Mastorakos G, Chrousos GP 1994 Final stature in patients with endogenous Cushing’s syndrome. J Clin Endocrinol Metab 79:1082-1085Magiakou MA, Mastorakos G, Chrousos GP 1994 Final stature in patients with endogenous Cushing’s syndrome. J Clin Endocrinol Metab 79:1082-1085Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA 2005 Iatrogenic Cushing’s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab 90:4394-4398Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA 2005 Iatrogenic Cushing’s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab 90:4394-4398Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK 2007 Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102-3107Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK 2007 Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 92:3102-3107Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M 1997 Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med 157:1651-1656Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M 1997 Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med 157:1651-1656Batista DL, Riar J, Keil M, Stratakis CA 2007 Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 120:e575-e586Batista DL, Riar J, Keil M, Stratakis CA 2007 Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 120:e575-e586Bulow B, Jansson S, Juhlin C, Steen L, Thoren M, Wahrenberg H, Valdemarsson S, Wangberg B, Ahren B 2006 Adrenal incidentaloma—follow-up results from a Swedish prospective study. Eur J Endocrinol 154:419-423Bulow B, Jansson S, Juhlin C, Steen L, Thoren M, Wahrenberg H, Valdemarsson S, Wangberg B, Ahren B 2006 Adrenal incidentaloma—follow-up results from a Swedish prospective study. Eur J Endocrinol 154:419-423Libe R, Dall’Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B 2002 Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 147:489-494Libe R, Dall’Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B 2002 Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 147:489-494Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A 2003 Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab 88:5808-5813Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A 2003 Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab 88:5808-5813Reimondo G, Pia A, Allasino B, Tassone F, Bovio S, Borretta G, Angeli A, Terzolo M 2007 Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol (Oxf) 67:225-229Reimondo G, Pia A, Allasino B, Tassone F, Bovio S, Borretta G, Angeli A, Terzolo M 2007 Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol (Oxf) 67:225-229Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L 2002 Overnight dexamethasone suppression test: a reliable screen for Cushing’s syndrome in the obese. Obes Res 10:1217-1221Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L 2002 Overnight dexamethasone suppression test: a reliable screen for Cushing’s syndrome in the obese. Obes Res 10:1217-1221Anderson Jr GH, Blakeman N, Streeten DH 1994 The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12:609-615Anderson Jr GH, Blakeman N, Streeten DH 1994 The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12:609-615Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T 2004 Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27:193-202Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T 2004 Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27:193-202Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V, Scillitani A 2007 Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 147:541-548Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V, Scillitani A 2007 Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 147:541-548Klose M, Lange M, Rasmussen AK, Skakkebaek NE, Hilsted L, Haug E, Andersen M, Feldt-Rasmussen U 2007 Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab 92:1326-1333Klose M, Lange M, Rasmussen AK, Skakkebaek NE, Hilsted L, Haug E, Andersen M, Feldt-Rasmussen U 2007 Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab 92:1326-1333Findling JW, Pinkstaff SM, Shaker JL, Raff H, Nelson JC 1998 Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. Endocrinologist 8:51-54Findling JW, Pinkstaff SM, Shaker JL, Raff H, Nelson JC 1998 Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. Endocrinologist 8:51-54Meikle AW, Findling J, Kushnir MM, Rockwood AL, Nelson GJ, Terry AH 2003 Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. J Clin Endocrinol Metab 88:3521-3524Meikle AW, Findling J, Kushnir MM, Rockwood AL, Nelson GJ, Terry AH 2003 Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. J Clin Endocrinol Metab 88:3521-3524Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC 1997 Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 82:151-155Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC 1997 Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 82:151-155Turpeinen U, Markkanen H, Valimaki M, Stenman UH 1997 Determination of urinary free cortisol by HPLC. Clin Chem 43:1386-1391Turpeinen U, Markkanen H, Valimaki M, Stenman UH 1997 Determination of urinary free cortisol by HPLC. Clin Chem 43:1386-1391Nickelsen T, Lissner W, Schoffling K 1989 The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. Exp Clin Endocrinol 94:275-280Nickelsen T, Lissner W, Schoffling K 1989 The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. Exp Clin Endocrinol 94:275-280Qureshi AC, Bahri A, Breen LA, Barnes SC, Powrie JK, Thomas SM, Carroll PV 2007 The influence of the route of oestrogen administration on serum levels of cortisolbinding globulin and total cortisol. Clin Endocrinol (Oxf) 66:632-635Qureshi AC, Bahri A, Breen LA, Barnes SC, Powrie JK, Thomas SM, Carroll PV 2007 The influence of the route of oestrogen administration on serum levels of cortisolbinding globulin and total cortisol. Clin Endocrinol (Oxf) 66:632-635

The authors declare that there are no conflicts of interest present.